Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109550638 | 10955063 | 8 | F | 201110 | 20160711 | 20150325 | 20160718 | EXP | PHHY2015AR035492 | NOVARTIS | 65.63 | YR | F | Y | 0.00000 | 20160718 | MD | AR | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109550638 | 10955063 | 1 | PS | DIOVAN | VALSARTAN | 1 | Unknown | 1.5 DF(80 UNIT NOT REPORTED), BID (1? TABLET IN THE MORNING AND 1 ? TABLET IN AFTERNOON EVERY 12HRS) | 21283 | 1.5 | DF | TABLET | BID | ||||||
| 109550638 | 10955063 | 2 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1.5 DF ( 80), QD | 21283 | 1.5 | DF | TABLET | QD | ||||||
| 109550638 | 10955063 | 3 | SS | DIOVAN | VALSARTAN | 1 | Oral | 160 MG, QD (MORNING) | 21283 | 160 | MG | TABLET | QD | ||||||
| 109550638 | 10955063 | 4 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 80 MG, IN THE EVENING | 21283 | 80 | MG | TABLET | |||||||
| 109550638 | 10955063 | 5 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 120 MG, QD (ONE TAB AND A HALF DAILY) (80 MG) | 21283 | 120 | MG | TABLET | QD | ||||||
| 109550638 | 10955063 | 6 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 2 DF, QD (160 UNITS UNSPECIFIED) | 21283 | 2 | DF | TABLET | QD | ||||||
| 109550638 | 10955063 | 7 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 1.5 DF(80 OT), QD | 21283 | 1.5 | DF | TABLET | QD | ||||||
| 109550638 | 10955063 | 8 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 2 DF, QD (80 OT) | 21283 | 2 | DF | TABLET | QD | ||||||
| 109550638 | 10955063 | 9 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 2 DF (80 UNITS NOT REPORTED), Q12H | 21283 | 2 | DF | TABLET | Q12H | ||||||
| 109550638 | 10955063 | 10 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 2 DF, QD (160 MG) | 21283 | 2 | DF | TABLET | QD | ||||||
| 109550638 | 10955063 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | 0 | ||||||||||
| 109550638 | 10955063 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109550638 | 10955063 | 1 | Hypertension |
| 109550638 | 10955063 | 11 | Product used for unknown indication |
| 109550638 | 10955063 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109550638 | 10955063 | HO |
| 109550638 | 10955063 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109550638 | 10955063 | Blood pressure increased | |
| 109550638 | 10955063 | Fall | |
| 109550638 | 10955063 | Feeling abnormal | |
| 109550638 | 10955063 | Gait disturbance | |
| 109550638 | 10955063 | Headache | |
| 109550638 | 10955063 | Hip fracture | |
| 109550638 | 10955063 | Hypertensive crisis | |
| 109550638 | 10955063 | Joint injury | |
| 109550638 | 10955063 | Memory impairment | |
| 109550638 | 10955063 | Nervousness | |
| 109550638 | 10955063 | Osteoarthritis | |
| 109550638 | 10955063 | Spinal disorder | |
| 109550638 | 10955063 | Spinal fracture | |
| 109550638 | 10955063 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |